DR LAL PATHLABS
Back to Balance Sheet
|
DR LAL PATHLABS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-82 Cr | ₹-83 Cr | ₹-42 Cr | ₹-37 Cr | ₹-33 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of DR LAL PATHLABS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-82 Cr |
| Mar2025 | ₹-83 Cr |
| Mar2024 | ₹-42 Cr |
| Mar2023 | ₹-37 Cr |
| Mar2022 | ₹-33 Cr |
How is Deferred Tax Assets / Liabilities of DR LAL PATHLABS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-82 Cr | Negative | |
| Mar2025 | ₹-83 Cr | Negative | |
| Mar2024 | ₹-42 Cr | Negative | |
| Mar2023 | ₹-37 Cr | Negative | |
| Mar2022 | ₹-33 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹31,482.0 Cr | 6.9% | 15.8% | 24.8% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹129,211.0 Cr | 2.1% | 4.3% | 21.1% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹109,639.0 Cr | 4.2% | -1.2% | -11.5% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹71,604.0 Cr | 0.4% | 0% | 15.5% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹70,971.6 Cr | 3.9% | 4.9% | 36.7% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹42,493.8 Cr | 6% | 6.2% | 4.1% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | 6.9% |
15.8% |
24.8% |
| SENSEX | 2% |
1.9% |
-5.2% |
You may also like the below Video Courses